HRTS Among Its Peers
End-of-day Nov 17, 2026 · 1 ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.2% | −2.9% | +3.8% | −1.5% | +8.5% | +13.0% | — | — | — | +47.9% |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$127 of every $1,000 in HRTS is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 12.73% | $1,273.22 | 5,107 | $7.3M |
| 2 | TMOThermo Fisher Scientific | Healthcare | 5.27% | $527.42 | 4,381 | $3.0M |
| 3 | RHHBYRoche AG | Healthcare | 4.38% | $437.54 | 41K | $2.5M |
| 4 | MRKMerck | Healthcare | 4.14% | $414.07 | 16K | $2.4M |
| 5 | KODKodiak Sciences | Healthcare | 3.79% | $379.09 | 22K | $2.2M |
| 6 | BBIOBridgebio Pharma | Healthcare | 3.67% | $367.05 | 27K | $2.1M |
| 7 | GILDGilead Sciences | Healthcare | 3.40% | $339.80 | 12K | $2.0M |
| 8 | UNHUnitedhealth Group | Healthcare | 3.14% | $313.68 | 4,372 | $1.8M |
| 9 | RVMDRevolution Medicines | Healthcare | 3.10% | $309.88 | 11K | $1.8M |
| 10 | DHRDanaher | Healthcare | 3.08% | $308.44 | 7,704 | $1.8M |
| 11 | NOVO-B.CONovo Nordisk A/S | Healthcare | 3.06% | $306.41 | 42K | $1.8M |
| 12 | AZN.LAstrazeneca | Healthcare | 2.95% | $294.96 | 9,157 | $1.7M |
| 13 | ABTAbbott Laboratories | Healthcare | 2.90% | $289.97 | 15K | $1.7M |
| 14 | JNJJohnson & Johnson | Healthcare | 2.88% | $287.89 | 5,851 | $1.7M |
| 15 | NOVN.SWNovartis AG | Healthcare | 2.86% | $286.31 | 10K | $1.6M |
HRTS has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 12.73% |
| 2 | TMO | Thermo Fisher Scientific | 5.27% |
| 3 | RHHBY | Roche AG | 4.38% |
| 4 | MRK | Merck & | 4.14% |
| 5 | KOD | Kodiak Sciences | 3.79% |
| 6 | BBIO | Bridgebio Pharma | 3.67% |
| 7 | GILD | Gilead Sciences | 3.40% |
| 8 | UNH | Unitedhealth Group | 3.14% |
| 9 | RVMD | Revolution Medicines | 3.10% |
| 10 | DHR | Danaher | 3.08% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| HRTS | 0.54 | 0.85 | 17.2% | −11.0% | 0.48 | $99 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | $0.47 |
| Dec 11, 2024 | Dec 12, 2024 | $0.47 |